Literature DB >> 17207945

Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy.

J B Brubach1, V Jannin, B Mahler, C Bourgaux, P Lessieur, P Roy, M Ollivon.   

Abstract

Physical and thermal properties of glyceryl behenate (Compritol 888 ATO) used as sustained-release matrix in pharmaceutical applications are studied by coupled time-resolved synchrotron X-ray diffraction and Differential Scanning Calorimetry combined with Infrared Spectroscopy. With these techniques, all polymorphs formed in glyceryl behenate, analyzed as received and after various thermal treatments from quenching to slow crystallization, are characterized. By using different well-controlled mixtures of mono-, di- and tribehenate, we identify each lamellar phase observed in the glyceryl behenate. Finally the influence of the crystallization rate on the formation of preferential conformations was also analyzed in order to bring insights into the polymorphism of glyceryl behenate. By changing the crystallization rate of the sample, it was shown that one can favor the formation of preferential polymorphs in the sample. In particular the crystallization at 10 degrees C/min seems to be well adapted for producing a single lamellar phase with a period of 60.9 A while a crystallization rate of 0.4 degrees C/min produces three different lamellar phases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17207945     DOI: 10.1016/j.ijpharm.2006.11.057

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

1.  Novel Curcumin-Resveratrol Solid Nanoparticles Synergistically Inhibit Proliferation of Melanoma Cells.

Authors:  Gayathri Heenatigala Palliyage; Noor Hussein; Michael Mimlitz; Catherine Weeder; Marya Hassan A Alnasser; Somnath Singh; Andrew Ekpenyong; Amit K Tiwari; Harsh Chauhan
Journal:  Pharm Res       Date:  2021-05-12       Impact factor: 4.200

2.  Solid lipid budesonide microparticles for controlled release inhalation therapy.

Authors:  Matteo Mezzena; Santo Scalia; Paul M Young; Daniela Traini
Journal:  AAPS J       Date:  2009-11-12       Impact factor: 4.009

3.  Mechanistic evaluation of the effect of sintering on Compritol 888 ATO matrices.

Authors:  Monica Rao; Anuradha Ranpise; Sameer Borate; Kaushik Thanki
Journal:  AAPS PharmSciTech       Date:  2009-03-31       Impact factor: 3.246

4.  Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinol.

Authors:  Nagendra S Punyamurthula; Tushar Hingorani; Goutham Adelli; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  Drug Dev Ind Pharm       Date:  2015-12-07       Impact factor: 3.225

5.  Preparation and Characterization of Metformin Hydrochloride - Compritol 888 ATO Solid Dispersion.

Authors:  Sc Jagdale; Sa Patil; Bs Kuchekar; Ar Chabukswar
Journal:  J Young Pharm       Date:  2011-07

Review 6.  Solvent-free melting techniques for the preparation of lipid-based solid oral formulations.

Authors:  Karin Becker; Sharareh Salar-Behzadi; Andreas Zimmer
Journal:  Pharm Res       Date:  2015-03-19       Impact factor: 4.200

7.  Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.

Authors:  Rehab Nabil Shamma; Mona Hassan Aburahma
Journal:  Int J Nanomedicine       Date:  2014-11-26

8.  Rapamycin Loaded Solid Lipid Nanoparticles as a New Tool to Deliver mTOR Inhibitors: Formulation and in Vitro Characterization.

Authors:  Alice Polchi; Alessandro Magini; Jarosław Mazuryk; Brunella Tancini; Jacek Gapiński; Adam Patkowski; Stefano Giovagnoli; Carla Emiliani
Journal:  Nanomaterials (Basel)       Date:  2016-05-09       Impact factor: 5.076

9.  Nanostructured Lipid Carriers to Mediate Brain Delivery of Temazepam: Design and In Vivo Study.

Authors:  Nermin E Eleraky; Mahmoud M Omar; Hemat A Mahmoud; Heba A Abou-Taleb
Journal:  Pharmaceutics       Date:  2020-05-14       Impact factor: 6.321

Review 10.  Twin-Screw Melt Granulation for Oral Solid Pharmaceutical Products.

Authors:  Seth P Forster; Erin Dippold; Tiffany Chiang
Journal:  Pharmaceutics       Date:  2021-05-06       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.